Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization

Fig. 2

Comparison of overall survival and disease-free survival between the PA-TACE and non-TACE groups in HCC patients with γ-GT ≤ 54 U/L. (A, B), Overall survival and disease-free survival before PSM. (C, D), Overall survival and disease-free survival after PSM

Back to article page